Company intelligence / Profile preview

Nanophilia Inc.

Greater Seoul, Gyeonggi-do / Seoul Capital Area, South Koreananophilia.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Nanophilia has developed an ultra-sensitive nanoplasmonic-based diagnostic platform capable of detecting trace amounts of target substances in blood. The company is leveraging over 20 years of research to enable earlier and more precise detection of diseases such as Alzheimer’s and cancer. Their PicoSpot® SERS technology claims world-leading sensitivity for biomarker detection. The company is currently commercializing its IVD platform with scalability across diverse healthcare applications but has not yet disclosed clinical trial results or regulatory approvals[1][7].

Therapeutic areas: OncologyNeurology
Modalities: In vitro diagnostics (IVD)Nano/bio-technologiesSERS (Surface Enhanced Raman Scattering)LSPR (Localized Surface Plasmon Resonance)
Industry: Protein Biomarker Diagnostics

Partnerships

Granted a Deep-Tech TIPS project grant; no major pharma or biotech partnerships disclosed as of now[1].

Beyond the preview

Go deeper on Nanophilia Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanophilia Inc..

Explore the full profile